{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-199173","form_type":"8-K","ticker":"EW","cik":"0001099800","company_name":"Edwards Lifesciences Corp","filed_at":"2022-07-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.981392+00:00","generated_at":"2026-06-24T09:51:23.078730+00:00","sec_items":["1.01","2.03","1.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Edwards Lifesciences enters new $750M five-year revolving credit facility, replaces 2018 agreement","bullets":["New $750M unsecured multi-currency revolving credit facility matures July 15, 2027.","Pricing improved vs. 2018 facility; margin tied to leverage ratio or debt ratings.","Facility includes options for increase up to $250M additional and multicurrency sub-limits.","No amounts drawn as of July 15, 2022; proceeds for general corporate purposes and refinancing.","Terminated the existing 2018 credit agreement on same date."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-199173","json":"https://secwatch.observer/filing/0001193125-22-199173.json","markdown":"https://secwatch.observer/filing/0001193125-22-199173.md","text":"https://secwatch.observer/filing/0001193125-22-199173.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099800/000119312522199173/0001193125-22-199173-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099800/000119312522199173/d383535d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T09:51:23.078730+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}